{"count": 8, "results": [{"_id": "39365598", "pmid": 39365598, "title": "Efficacy and safety of atenolol versus propranolol for treatment of infantile haemangioma: A narrative review.", "journal": "Clin Exp Dermatol", "authors": ["Shi M", "Wargon O", "Tatian A"], "date": "2024-10-04T00:00:00Z", "doi": "10.1093/ced/llae401", "meta_date_publication": "2024 Oct 4", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50258.023, "text_hl": "Hence, @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, a hydrophilic @GENE_MS4A1 @GENE_931 @@@beta-1@@@ selective blocker, has demonstrated similar efficacy and potentially greater tolerability, being less likely to cause @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@sleep disturbances@@@ given its inability to cross the blood brain barrier, and a decrease in bronchial reactivity. ", "citations": {"NLM": "Shi M, Wargon O, Tatian A. Efficacy and safety of atenolol versus propranolol for treatment of infantile haemangioma: A narrative review. Clin Exp Dermatol. 2024 Oct 4;():. PMID: 39365598", "BibTeX": "@article{39365598, title={Efficacy and safety of atenolol versus propranolol for treatment of infantile haemangioma: A narrative review.}, author={Shi M and Wargon O and Tatian A}, journal={Clin Exp Dermatol}}"}}, {"_id": "27310994", "pmid": 27310994, "pmcid": "PMC4998480", "title": "Oral atenolol therapy for proliferating infantile hemangioma", "journal": "Medicine (Baltimore)", "authors": ["Ji Y", "Wang Q", "Chen S", "Xiang B", "Xu Z", "Li Y", "Zhong L", "Jiang X", "Yang X"], "date": "2016-06-01T00:00:00Z", "doi": "10.1097/MD.0000000000003908", "meta_date_publication": "2016 Jun", "meta_volume": "95", "meta_issue": "24", "meta_pages": "e3908", "score": 50069.02, "text_hl": "Before starting @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, each child underwent echocardiography to exclude contraindications to @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ treatment. ", "citations": {"NLM": "Ji Y, Wang Q, Chen S, Xiang B, Xu Z, Li Y, Zhong L, Jiang X, Yang X. Oral atenolol therapy for proliferating infantile hemangioma Medicine (Baltimore). 2016 Jun;95(24):e3908. PMID: 27310994", "BibTeX": "@article{27310994, title={Oral atenolol therapy for proliferating infantile hemangioma}, author={Ji Y and Wang Q and Chen S and Xiang B and Xu Z and Li Y and Zhong L and Jiang X and Yang X}, journal={Medicine (Baltimore)}, volume={95}, number={24}, pages={e3908}}"}}, {"_id": "30983047", "pmid": 30983047, "title": "Atenolol as an alternative to propranolol for the management of sleep disturbances in the treatment of infantile hemangiomas.", "journal": "Pediatr Dermatol", "authors": ["Gumina ME", "Yan AC"], "date": "2019-07-01T00:00:00Z", "doi": "10.1111/pde.13839", "meta_date_publication": "2019 Jul", "meta_volume": "36", "meta_issue": "4", "meta_pages": "556-557", "score": 50068.62, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ as an alternative to @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ for the management of @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@sleep disturbances@@@ in the treatment of @DISEASE_Hemangioma_capillary_infantile @DISEASE_MESH:C535860 @@@infantile hemangiomas@@@.", "citations": {"NLM": "Gumina ME, Yan AC. Atenolol as an alternative to propranolol for the management of sleep disturbances in the treatment of infantile hemangiomas. Pediatr Dermatol. 2019 Jul;36(4):556-557. PMID: 30983047", "BibTeX": "@article{30983047, title={Atenolol as an alternative to propranolol for the management of sleep disturbances in the treatment of infantile hemangiomas.}, author={Gumina ME and Yan AC}, journal={Pediatr Dermatol}, volume={36}, number={4}, pages={556-557}}"}}, {"_id": "4054195", "pmid": 4054195, "title": "Atenolol versus pindolol: side-effects in hypertension.", "journal": "Eur J Clin Pharmacol", "authors": ["Foerster EC", "Greminger P", "Siegenthaler W", "Vetter H", "Vetter W"], "date": "1985-01-01T00:00:00Z", "doi": "10.1007/BF00543717", "meta_date_publication": "1985", "meta_volume": "28 Suppl", "meta_issue": "", "meta_pages": "89-91", "score": 50067.2, "text_hl": "As the study progressed there was a reduction in the frequency of @DISEASE_Fatigue @DISEASE_MESH:D005221 @@@fatigue@@@ (p less than 0.03) and dreams (p less than 0.05) in both groups, whereas @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@sleep disturbances@@@ significantly increased under @CHEMICAL_Pindolol @CHEMICAL_MESH:D010869 @@@pindolol@@@ (p less than 0.05) but decreased under @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (p less than 0.05). ", "citations": {"NLM": "Foerster EC, Greminger P, Siegenthaler W, Vetter H, Vetter W. Atenolol versus pindolol: side-effects in hypertension. Eur J Clin Pharmacol. 1985;28 Suppl():89-91. PMID: 4054195", "BibTeX": "@article{4054195, title={Atenolol versus pindolol: side-effects in hypertension.}, author={Foerster EC and Greminger P and Siegenthaler W and Vetter H and Vetter W}, journal={Eur J Clin Pharmacol}, volume={28 Suppl}, pages={89-91}}"}}, {"_id": "2205704", "pmid": 2205704, "title": "Comparison of the side-effects of pindolol and atenolol in the treatment of hypertension.", "journal": "J Intern Med", "authors": ["Abrahamsen AM", "Digranes O", "Gisholt K"], "date": "1990-09-01T00:00:00Z", "doi": "10.1111/j.1365-2796.1990.tb00221.x", "meta_date_publication": "1990 Sep", "meta_volume": "228", "meta_issue": "3", "meta_pages": "219-22", "score": 50064.043, "text_hl": "After 1 month there was significantly less @DISEASE_Bradycardia @DISEASE_MESH:D001919 @@@bradycardia@@@ (P less than 0.01), cold hands and feet (P less than 0.05) and tiredness (P less than 0.02) in the @CHEMICAL_Pindolol @CHEMICAL_MESH:D010869 @@@pindolol@@@ group, and less @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@sleep disturbance@@@ (P less than 0.02) in the @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ group. ", "citations": {"NLM": "Abrahamsen AM, Digranes O, Gisholt K. Comparison of the side-effects of pindolol and atenolol in the treatment of hypertension. J Intern Med. 1990 Sep;228(3):219-22. PMID: 2205704", "BibTeX": "@article{2205704, title={Comparison of the side-effects of pindolol and atenolol in the treatment of hypertension.}, author={Abrahamsen AM and Digranes O and Gisholt K}, journal={J Intern Med}, volume={228}, number={3}, pages={219-22}}"}}, {"_id": "27710806", "pmid": 27710806, "title": "Sleep-related changes in cardiovascular autonomic regulation in left coronary artery ligation rats: Neural mechanism facilitating arrhythmia after myocardial infarction.", "journal": "Int J Cardiol", "authors": ["Lin WL", "Lo LW", "Chen HR", "Lai CT", "Yamada S", "Liu SH", "Chou YH", "Chen SA", "Fu YC", "Kuo TB"], "date": "2016-12-15T00:00:00Z", "doi": "10.1016/j.ijcard.2016.09.121", "meta_date_publication": "2016 Dec 15", "meta_volume": "225", "meta_issue": "", "meta_pages": "65-72", "score": 50047.42, "text_hl": "CONCLUSIONS: Our results demonstrate significant @DISEASE_Sleep_Deprivation @DISEASE_MESH:D012892 @@@sleep fragmentations@@@ with @DISEASE_Hyperkinesis @DISEASE_MESH:D006948 @@@sympathetic hyperactivity@@@ during QS stages after MI, and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ could restore the @DISEASE_Autonomic_Nervous_System_Diseases @DISEASE_MESH:D001342 @@@autonomic dysfunction@@@ and @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@sleep disturbance@@@. ", "citations": {"NLM": "Lin WL, Lo LW, Chen HR, Lai CT, Yamada S, Liu SH, Chou YH, Chen SA, Fu YC, Kuo TB. Sleep-related changes in cardiovascular autonomic regulation in left coronary artery ligation rats: Neural mechanism facilitating arrhythmia after myocardial infarction. Int J Cardiol. 2016 Dec 15;225():65-72. PMID: 27710806", "BibTeX": "@article{27710806, title={Sleep-related changes in cardiovascular autonomic regulation in left coronary artery ligation rats: Neural mechanism facilitating arrhythmia after myocardial infarction.}, author={Lin WL and Lo LW and Chen HR and Lai CT and Yamada S and Liu SH and Chou YH and Chen SA and Fu YC and Kuo TB}, journal={Int J Cardiol}, volume={225}, pages={65-72}}"}}, {"_id": "3291558", "pmid": 3291558, "title": "Melatonin secretion related to side-effects of beta-blockers from the central nervous system.", "journal": "Acta Med Scand", "authors": ["Brismar K", "Hylander B", "Eliasson K", "Rössner S", "Wetterberg L"], "date": "1988-01-01T00:00:00Z", "doi": "10.1111/j.0954-6820.1988.tb17690.x", "meta_date_publication": "1988", "meta_volume": "223", "meta_issue": "6", "meta_pages": "525-30", "score": 50042.344, "text_hl": "After 4 weeks of treatment all beta-blockers reduced @CHEMICAL_Melatonin @CHEMICAL_MESH:D008550 @@@melatonin@@@ excretion, but the effect was significant only for @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@. @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@Sleep disturbance@@@ records revealed more disturbed nights in the @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ group compared with the @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ and the @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ groups, even when the difference in age between the groups was controlled for. ", "citations": {"NLM": "Brismar K, Hylander B, Eliasson K, Rössner S, Wetterberg L. Melatonin secretion related to side-effects of beta-blockers from the central nervous system. Acta Med Scand. 1988;223(6):525-30. PMID: 3291558", "BibTeX": "@article{3291558, title={Melatonin secretion related to side-effects of beta-blockers from the central nervous system.}, author={Brismar K and Hylander B and Eliasson K and Rössner S and Wetterberg L}, journal={Acta Med Scand}, volume={223}, number={6}, pages={525-30}}"}}, {"_id": "1969642", "pmid": 1969642, "title": "Beta-blockers and central nervous system side effects.", "journal": "Pharmacol Ther", "authors": ["McAinsh J", "Cruickshank JM"], "date": "1990-01-01T00:00:00Z", "doi": "10.1016/0163-7258(90)90092-g", "meta_date_publication": "1990", "meta_volume": "46", "meta_issue": "2", "meta_pages": "163-97", "score": 50038.85, "text_hl": "However, within this group of four drugs the incidence of these side effects is lowest with hydrophilic @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and generally highest with @CHEMICAL_Pindolol @CHEMICAL_MESH:D010869 @@@pindolol@@@ and @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@. ", "citations": {"NLM": "McAinsh J, Cruickshank JM. Beta-blockers and central nervous system side effects. Pharmacol Ther. 1990;46(2):163-97. PMID: 1969642", "BibTeX": "@article{1969642, title={Beta-blockers and central nervous system side effects.}, author={McAinsh J and Cruickshank JM}, journal={Pharmacol Ther}, volume={46}, number={2}, pages={163-97}}"}}]}